Neoadjuvant Chemotherapy in Stage III NSCLC
Neoadjuvant chemotherapy offers some significant potential advantages
for patients with stage III non-small-cell lung cancer, and the
current review explores the scientific literature about this
treatment.................
http://www.medscape.com/viewarticle/572004